Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 2022

View Archived Issues

New enzyme replacement therapy for the treatment of glutaric aciduria type 1 (GA-1)

GNT-0007: a novel gene therapy for the treatment of gamma-sarcoglycanopathy

An ACE2 decoy resistant to virus escape mutations neutralizes Omicron variant in vitro and in vivo

ILDONG Pharmaceutical synthesizes new CFTR modulators and/or PDE4 inhibitors

Palacky University describes neuroprotective cholestane derivatives

University of Ljubljana presents dual TLR7/NOD2 agonists

Evotec International discovers integrated stress response pathway modulators

Patient-derived antibody activates innate immune system

Mission Therapeutics patents USP30 inhibitors

Model Medicines granted request for pre-IND meeting with FDA for antiviral MDL-001

Sanofi describes enzyme replacement gene therapy for metachromatic leukodystrophy

rVCG-Pmp18.3, a novel Chlamydia abortus vaccine with promising efficacy in mice

RO-634, bispecific protein for the treatment of back of the eye disease

Burnet Institute and Moderna partner on novel mRNA vaccines for infectious diseases

Promising nonhuman primate data reported for CRISPR/Cas9-based therapy EDIT-103 for RHO-adRP

AAV9-cTnT-GSLA01, a gene therapy to treat LMNA dilated cardiomyopathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...